Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,334Revenue (TTM) $M191Net Margin (%)-38.9Altman Z-Score3.4
Enterprise Value $M6,104EPS (TTM) $-0.3Operating Margin %-14.7Piotroski F-Score6
P/E(ttm)--Beneish M-Score-0.2Pre-tax Margin (%)-38.9Higher ROA y-yY
Price/Book68.110-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales26.95-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow24.2y-y EBITDA Growth Rate %--ROA % (ttm)-15.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M292ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

EXEL is held by these investors:

EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARCHESI VINCENT TDirector 2017-04-03Sell10,000$21.3-1.5view
WYSZOMIERSKI JACK LDirector 2017-03-31Sell5,150$21.57-2.74view
Hessekiel JeffreyEVP and General Counsel 2017-03-27Sell6,884$21.02-0.19view
Hessekiel JeffreyEVP and General Counsel 2017-03-22Sell23,787$20.542.14view
FELDBAUM CARL BDirector 2017-03-20Sell10,000$21.77-3.63view
PAPADOPOULOS STELIOSDirector 2017-03-20Sell10,000$21.66-3.14view
WILLSEY LANCEDirector 2017-03-15Sell10,000$22.86-8.22view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2017-03-15Sell50,007$22.53-6.88view
COHEN CHARLESDirector 2017-03-13Sell10,000$21.82-3.85view
MARCHESI VINCENT TDirector 2017-03-10Sell40,000$21.98-4.55view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
Top Performing Contest Portfolios from 2016 Jan 17 2017 
7 Stocks Outperforming the Market Jan 12 2017 
Why You Should Be Using the Altman Z-Score Dec 18 2016 
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 

More From Other Websites
Read This Before You Buy Biotech Stocks Apr 23 2017
Here's Why the Best Is Yet to Come for Exelixis, Inc. Apr 20 2017
ETFs with exposure to Exelixis, Inc. : April 19, 2017 Apr 19 2017
Exelixis to Release First Quarter 2017 Financial Results on Monday, May 1, 2017 Apr 18 2017
Exelixis, Inc.: Time to Move On? Apr 18 2017
3 Stocks That Turned $5,000 Into More Than $18,000 in a Year or Less Apr 12 2017
Exelixis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Apr 04 2017
3 Winning Stocks You Never Saw Coming Apr 04 2017
Exelixis Further Reduces Indebtedness by Repaying Silicon Valley Bank Term Loan Mar 29 2017
Exelixis to Present at the Needham & Company Healthcare Conference on April 4 Mar 27 2017
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : March 27, 2017 Mar 27 2017
When Profit Makers Can Be Active Profit Takers Mar 16 2017
Why Exelixis Is Already Up 55% This Year Mar 15 2017
The 3 Most Important Numbers for Exelixis, Inc. Mar 14 2017
Top Stocks That Are Already Crushing the Market in 2017 Mar 13 2017
3 Horrible Stocks for Retirees Mar 12 2017
Is Exelixis' Balance Sheet Safe? Mar 07 2017
3 Factors That Drove Exelixis, Inc. Higher By 19% in February Mar 07 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)